Khiron Life Sciences Corp.
Rank 49
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$2.4351
USD
0.00%
Market cap
$224,361,921
Total volume
$1,816,685
Shares outstanding
92,137,695
Rank 49
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$1,539,452
|
84.74% |
$2.4351
|
| KHRNF |
Total volume
$277,233
|
15.26% |
Stock price
$2.4300
|
Chart